BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 36075462)

  • 1. Repositioning of FDA-Approved antifungal agents to interrogate Acyl-CoA synthetase long chain family member 4 (ACSL4) in ferroptosis.
    Marteau R; Ravez S; Mazhari Dorooee D; Bouchaoui H; Porte K; Devedjian JC; Melnyk P; Devos D; Frédérick R; El Bakali J
    Biochem Pharmacol; 2022 Oct; 204():115239. PubMed ID: 36075462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of ACSL4 attenuates ferroptotic damage after pulmonary ischemia-reperfusion.
    Xu Y; Li X; Cheng Y; Yang M; Wang R
    FASEB J; 2020 Dec; 34(12):16262-16275. PubMed ID: 33070393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of ACSL4 as a biomarker and contributor of ferroptosis.
    Yuan H; Li X; Zhang X; Kang R; Tang D
    Biochem Biophys Res Commun; 2016 Sep; 478(3):1338-43. PubMed ID: 27565726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acyl-Coenzyme A Synthetase Long-Chain Family Member 4 Is Involved in Viral Replication Organelle Formation and Facilitates Virus Replication via Ferroptosis.
    Kung YA; Chiang HJ; Li ML; Gong YN; Chiu HP; Hung CT; Huang PN; Huang SY; Wang PY; Hsu TA; Brewer G; Shih SR
    mBio; 2022 Feb; 13(1):e0271721. PubMed ID: 35038927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ischemia-induced ACSL4 activation contributes to ferroptosis-mediated tissue injury in intestinal ischemia/reperfusion.
    Li Y; Feng D; Wang Z; Zhao Y; Sun R; Tian D; Liu D; Zhang F; Ning S; Yao J; Tian X
    Cell Death Differ; 2019 Nov; 26(11):2284-2299. PubMed ID: 30737476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ACSL4-Mediated Ferroptosis and Its Potential Role in Central Nervous System Diseases and Injuries.
    Jia B; Li J; Song Y; Luo C
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hsp90 induces Acsl4-dependent glioma ferroptosis via dephosphorylating Ser637 at Drp1.
    Miao Z; Tian W; Ye Y; Gu W; Bao Z; Xu L; Sun G; Li C; Tu Y; Chao H; Lam SM; Liu N; Ji J
    Cell Death Dis; 2022 Jun; 13(6):548. PubMed ID: 35697672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Context-dependent regulation of ferroptosis sensitivity.
    Magtanong L; Mueller GD; Williams KJ; Billmann M; Chan K; Armenta DA; Pope LE; Moffat J; Boone C; Myers CL; Olzmann JA; Bensinger SJ; Dixon SJ
    Cell Chem Biol; 2022 Sep; 29(9):1409-1418.e6. PubMed ID: 35809566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ACSL4 contributes to ferroptosis-mediated rhabdomyolysis in exertional heat stroke.
    He S; Li R; Peng Y; Wang Z; Huang J; Meng H; Min J; Wang F; Ma Q
    J Cachexia Sarcopenia Muscle; 2022 Jun; 13(3):1717-1730. PubMed ID: 35243801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Acyl-CoA Synthetase Long-Chain Family Member 4 Facilitates Neurological Recovery After Stroke by Regulation Ferroptosis.
    Chen J; Yang L; Geng L; He J; Chen L; Sun Q; Zhao J; Wang X
    Front Cell Neurosci; 2021; 15():632354. PubMed ID: 33889074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ACSL3 and ACSL4, Distinct Roles in Ferroptosis and Cancers.
    Yang Y; Zhu T; Wang X; Xiong F; Hu Z; Qiao X; Yuan X; Wang D
    Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ALKBH5 targets ACSL4 mRNA stability to modulate ferroptosis in hyperbilirubinemia-induced brain damage.
    Zhou J; Tang J; Zhang C; Li G; Lin X; Liao S; Luo J; Yu G; Zheng F; Guo Z; Shao W; Hu H; Xu L; Wu S; Li H
    Free Radic Biol Med; 2024 Aug; 220():271-287. PubMed ID: 38734267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACSL4 suppresses glioma cells proliferation via activating ferroptosis.
    Cheng J; Fan YQ; Liu BH; Zhou H; Wang JM; Chen QX
    Oncol Rep; 2020 Jan; 43(1):147-158. PubMed ID: 31789401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACSL4 deficiency confers protection against ferroptosis-mediated acute kidney injury.
    Wang Y; Zhang M; Bi R; Su Y; Quan F; Lin Y; Yue C; Cui X; Zhao Q; Liu S; Yang Y; Zhang D; Cao Q; Gao X
    Redox Biol; 2022 May; 51():102262. PubMed ID: 35180475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of ACSL4 ameliorates tubular ferroptotic cell death and protects against fibrotic kidney disease.
    Dai Y; Chen Y; Mo D; Jin R; Huang Y; Zhang L; Zhang C; Gao H; Yan Q
    Commun Biol; 2023 Sep; 6(1):907. PubMed ID: 37670055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Necroptosis and ferroptosis are alternative cell death pathways that operate in acute kidney failure.
    Müller T; Dewitz C; Schmitz J; Schröder AS; Bräsen JH; Stockwell BR; Murphy JM; Kunzendorf U; Krautwald S
    Cell Mol Life Sci; 2017 Oct; 74(19):3631-3645. PubMed ID: 28551825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACSL4 exacerbates ischemic stroke by promoting ferroptosis-induced brain injury and neuroinflammation.
    Cui Y; Zhang Y; Zhao X; Shao L; Liu G; Sun C; Xu R; Zhang Z
    Brain Behav Immun; 2021 Mar; 93():312-321. PubMed ID: 33444733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition.
    Doll S; Proneth B; Tyurina YY; Panzilius E; Kobayashi S; Ingold I; Irmler M; Beckers J; Aichler M; Walch A; Prokisch H; Trümbach D; Mao G; Qu F; Bayir H; Füllekrug J; Scheel CH; Wurst W; Schick JA; Kagan VE; Angeli JP; Conrad M
    Nat Chem Biol; 2017 Jan; 13(1):91-98. PubMed ID: 27842070
    [TBL] [Abstract][Full Text]